{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:10:44Z","timestamp":1789099844086,"version":"build-2803163510"},"reference-count":125,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.humimm.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T19:27:11Z","timestamp":1661542031000},"page":"674-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Current donor selection strategies for allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"83","author":[{"given":"Olga A.","family":"Timofeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Carmelle","family":"Philogene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuheng Jennifer","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.humimm.2022.08.007_b0005","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.bbmt.2019.08.002","article-title":"Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program","volume":"25","author":"Pidala","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.humimm.2022.08.007_b0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current Use and Trends in Hematopoietic Cell Transplantation in the United States","volume":"23","author":"D'Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0015","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41409-020-0826-4","article-title":"The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus","volume":"55","author":"Passweg","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2022.08.007_b0020","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10428194.2017.1344906","article-title":"A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center","volume":"59","author":"Mohyuddin","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.humimm.2022.08.007_b0025","doi-asserted-by":"crossref","first-page":"646","DOI":"10.7326\/0003-4819-120-8-199404150-00004","article-title":"Identical-twin bone marrow transplants for leukemia","volume":"120","author":"Gale","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.humimm.2022.08.007_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2022.04.008","article-title":"Current HLA testing recommendations to support HCT","author":"Yu","year":"2022","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2022.08.007_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/iji.12527","article-title":"BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell transplantation","volume":"48","author":"Little","year":"2021","journal-title":"Int. J. Immunogenet."},{"issue":"12","key":"10.1016\/j.humimm.2022.08.007_b0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.humimm.2022.08.007_b0045","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":"High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bbmt.2007.04.010","article-title":"HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival","volume":"13","author":"Loiseau","year":"2007","journal-title":"Biology of blood and marrow transplantation : Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"18","key":"10.1016\/j.humimm.2022.08.007_b0055","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1182\/blood-2013-02-482547","article-title":"High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis","volume":"122","author":"F\u00fcrst","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humimm.2022.08.007_b0060","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1182\/blood-2014-10-604785","article-title":"Biological significance of HLA locus matching in unrelated donor bone marrow transplantation","volume":"125","author":"Morishima","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.humimm.2022.08.007_b0065","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2009-09-244525","article-title":"The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure","volume":"115","author":"Spellman","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humimm.2022.08.007_b0070","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000502263","article-title":"HLA Matching in Unrelated Stem Cell Transplantation up to Date","volume":"46","author":"F\u00fcrst","year":"2019","journal-title":"Transfus Med Hemother"},{"issue":"19","key":"10.1016\/j.humimm.2022.08.007_b0075","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020001888","article-title":"Naive T-cell depletion in stem cell transplantation","volume":"4","author":"Bleakley","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2022.08.007_b0080","doi-asserted-by":"crossref","first-page":"617","DOI":"10.12688\/f1000research.10990.1","article-title":"Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation","volume":"6","author":"Petersdorf","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.humimm.2022.08.007_b0085","unstructured":"(JACIE) FFTAOCTF-JACIaE: Eighth Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing and Administration, Version 8.1. Allogeneic and Autologous Donor Selection, Evaluation, and Management, 2021, p 1."},{"key":"10.1016\/j.humimm.2022.08.007_b0090","article-title":"Donor selection based on NK alloreactivity for patients with hematological malignancies","author":"Zhang","year":"2022","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2022.08.007_b0095","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.2015.141119","article-title":"How to select the best available related or unrelated donor of hematopoietic stem cells?","volume":"101","author":"Tiercy","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.humimm.2022.08.007_b0105","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1200\/JCO.2006.08.0952","volume":"24","author":"Yakoub-Agha","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.humimm.2022.08.007_b0110","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(19)30158-9","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"issue":"10","key":"10.1016\/j.humimm.2022.08.007_b0115","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/bmt.2013.50","article-title":"Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS","volume":"48","author":"Robin","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbmt.2018.12.768","article-title":"Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study","volume":"25","author":"Mayor","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0125","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1016\/j.bbmt.2019.05.026","article-title":"Regarding \u201cRecipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study\u201d","volume":"25","author":"Hurley","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"10.1016\/j.humimm.2022.08.007_b0130","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1200\/JCO.20.03643","article-title":"Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation","volume":"39","author":"Mayor","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23682-y","article-title":"Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation","volume":"8","author":"Koskela","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2022.08.007_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1399-0039.2006.759_4.x","article-title":"Clinical importance of HLA-DPB1 in haematopoietic cell transplantation","volume":"69","author":"Shaw","year":"2007","journal-title":"Tissue Antigens"},{"issue":"13","key":"10.1016\/j.humimm.2022.08.007_b0150","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","article-title":"The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation","volume":"110","author":"Shaw","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood-2015-12-686238","article-title":"Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT","volume":"128","author":"Crivello","year":"2016","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.humimm.2022.08.007_b0160","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humimm.2022.08.007_b0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1500140","article-title":"High HLA-DP Expression and Graft-versus-Host Disease","volume":"373","author":"Petersdorf","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2022.08.007_b0170","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2003-04-1279","article-title":"A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation","volume":"103","author":"Zino","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humimm.2022.08.007_b0175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2007.05.010","article-title":"Frequency and targeted detection of HLA-DPB1 T-cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation","volume":"13","author":"Zino","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2022.08.007_b0180","article-title":"The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis","volume":"11","author":"Mytilineos","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2022.08.007_b0185","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/bmt.2017.96","article-title":"Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8\/8 matched unrelated donor hematopoietic cell transplantation","volume":"52","author":"Fleischhauer","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.humimm.2022.08.007_b0190","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.TP.0000122225.10296.10","article-title":"Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease","volume":"77","author":"Gallardo","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2022.08.007_b0195","first-page":"21","article-title":"HLA-DPB1 mismatch and acute graft-versus host disease in HLA-identical sibling donors","volume":"12","author":"Mosaad","year":"2005","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.humimm.2022.08.007_b0200","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.280055","article-title":"Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation","author":"Ruggeri","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2022.08.007_b0205","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022015708","article-title":"A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation","author":"Arrieta-Bola\u00f1os","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0210","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1046\/j.1365-2141.2001.02655.x","article-title":"The biological significance of HLA-DP gene variation in haematopoietic cell transplantation","volume":"112","author":"Petersdorf","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"22","key":"10.1016\/j.humimm.2022.08.007_b0215","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2013-02-481945","article-title":"Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3\/4\/5 associate with adverse outcomes in hematopoietic stem cell transplantation","volume":"121","author":"Fern\u00e1ndez-Vi\u00f1a","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.007_b0220","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","article-title":"The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors","volume":"99","author":"Morishima","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humimm.2022.08.007_b0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","article-title":"HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation","volume":"17","author":"Woolfrey","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"10.1016\/j.humimm.2022.08.007_b0230","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2014-09-599969","article-title":"HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation","volume":"124","author":"Petersdorf","year":"2014","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.humimm.2022.08.007_b0235","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1182\/blood-2013-01-480343","article-title":"The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors","volume":"121","author":"Hurley","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0240","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2013-10-532671","article-title":"Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation","volume":"123","author":"Fernandez-Vi\u00f1a","year":"2014","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.humimm.2022.08.007_b0245","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1056\/NEJMoa011826","article-title":"Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation","volume":"345","author":"Petersdorf","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.humimm.2022.08.007_b0250","doi-asserted-by":"crossref","first-page":"27645","DOI":"10.18632\/oncotarget.15291","article-title":"Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis","volume":"8","author":"Tie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2022.08.007_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.771449","article-title":"HLA-DRB3\/4\/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation","volume":"12","author":"Tsamadou","year":"2021","journal-title":"Front. Immunol."},{"issue":"24","key":"10.1016\/j.humimm.2022.08.007_b0260","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.20.00265","article-title":"Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation","volume":"38","author":"Petersdorf","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2022.08.007_b0265","first-page":"270","article-title":"Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation","volume":"6","author":"Sajulga","year":"2022","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0270","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.humimm.2022.08.007_b0275","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.humimm.2022.08.007_b0280","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2020005743","article-title":"HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation","author":"Petersdorf","year":"2020","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.humimm.2022.08.007_b0285","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-144669","article-title":"HLA-B Leader Dimorphism Impacts on Outcomes of HLA-Matched Related\/Unrelated Transplantation: Analysis of the Japanese Society for Transplantation and Cellular Therapy","volume":"138","author":"Kanaya","year":"2021","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.humimm.2022.08.007_b0290","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.19.00396","article-title":"Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT","volume":"38","author":"Mehta","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2022.08.007_b0300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/bloodadvances.2016002196","article-title":"Related haploidentical donors are a better choice than matched unrelated donors: Point","volume":"1","author":"Fuchs","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2022.08.007_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5030035","article-title":"Role of alphabeta T-cell Depletion in Prevention of Graft versus Host Disease","volume":"5","author":"Abdelhakim","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.humimm.2022.08.007_b0310","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3389\/fimmu.2019.02769","article-title":"The Evolution of T-cell Depleted Haploidentical Transplantation","volume":"10","author":"Aversa","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.08.007_b0315","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T-cell dysfunction and suppression","volume":"129","author":"Wachsmuth","year":"2019","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.humimm.2022.08.007_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-021-00640-9","article-title":"Which is better, HLA-matched sibling or haploidentical transplantation?","volume":"18","author":"Zheng","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2022.08.007_b0325","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1097\/MPH.0000000000001841","article-title":"Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning","volume":"43","author":"Sharma","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2022.08.007_b0330","series-title":"Haploidentical Transplantation","first-page":"175","article-title":"Haploidentical Transplants for Nonmalignant Diseases in Children","author":"Seitz","year":"2018"},{"key":"10.1016\/j.humimm.2022.08.007_b0335","series-title":"Haploidentical Transplantation","first-page":"219","article-title":"Haploidentical Transplants: Nonmalignant Diseases in Adults","author":"Meade","year":"2018"},{"key":"10.1016\/j.humimm.2022.08.007_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2022.04.012","article-title":"Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate's antibody profile for donor selection","author":"Bettinotti","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2022.08.007_b0340","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01217","article-title":"The Graft-Versus-Leukemia Effect in AML","volume":"9","author":"Sweeney","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.humimm.2022.08.007_b0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3324\/haematol.2016.144139","article-title":"Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide","volume":"102","author":"McCurdy","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0355","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood.2021011281","article-title":"HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis","volume":"138","author":"Gooptu","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0360","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0365","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-015-0182-9","article-title":"Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets","volume":"8","author":"Chang","year":"2015","journal-title":"Journal of Hematology & Oncology"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0370","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.bbmt.2015.05.001","article-title":"Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation","volume":"21","author":"Ciurea","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2022.08.007_b0375","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/bmt.2014.331","article-title":"Donor HLA-specific Abs: to BMT or not to BMT?","volume":"50","author":"Leffell","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"22","key":"10.1016\/j.humimm.2022.08.007_b0380","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.3472.3472","article-title":"Mother Donors Improve Outcomes after HLA Haploidentical Hematopoietic Transplantation: A Retrospective Study By the Cell Therapy and Immunobiology Working Party of the EBMT","volume":"128","author":"Velardi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.007_b0385","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fimmu.2012.00135","article-title":"Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation","volume":"3","author":"Hirayama","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.08.007_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2022.01.010","article-title":"Tools for optimizing risk assessment in hematopoietic cell transplant - What can we get away with?","author":"Hod-Dvorai","year":"2022","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0395","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbmt.2018.10.021","article-title":"Role of Regulatory T-cells in Noninherited Maternal Antigen-Related Tolerance in Cord Blood: An in Vitro Study","volume":"25","author":"Kwok","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.humimm.2022.08.007_b0400","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.humimm.2022.08.007_b0405","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2021-149718","article-title":"Impact of Donor Age and Relationship on Outcomes of Peripheral Blood Haploidentical Hematopoietic Cell Transplantation","volume":"138","author":"Pruitt","year":"2021","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.humimm.2022.08.007_b0410","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200006223422501","article-title":"Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical Sibling","volume":"342","author":"Rocha","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.humimm.2022.08.007_b0415","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-Blood Transplantation in Patients with Minimal Residual Disease","volume":"375","author":"Milano","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2022.08.007_b0420","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.humimm.2022.08.007_b0425","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.bbmt.2020.07.030","article-title":"Guidelines for Cord Blood Unit Selection","volume":"26","author":"Politikos","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.humimm.2022.08.007_b0430","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbmt.2017.03.006","article-title":"Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies","volume":"23","author":"Barker","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2022.08.007_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194875","article-title":"Human Leukocyte Antigen and Red Blood Cells Impact Umbilical Cord Blood CD34(+) Cell Viability after Thawing","volume":"20","author":"Vanegas","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.humimm.2022.08.007_b0440","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1182\/blood-2014-03-566216","article-title":"Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice","volume":"124","author":"Purtill","year":"2014","journal-title":"Blood"},{"issue":"4-5","key":"10.1016\/j.humimm.2022.08.007_b0445","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3727\/096368914X678481","article-title":"Plasma-depleted versus red cell-reduced umbilical cord blood","volume":"23","author":"Young","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.humimm.2022.08.007_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/463031","article-title":"A review of factors influencing the banking of collected umbilical cord blood units","volume":"2013","author":"Allan","year":"2013","journal-title":"Stem Cells Int"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/hematology.2019000056","article-title":"Optimizing cord blood selection","volume":"2019","author":"Ruggeri","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.humimm.2022.08.007_b0460","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/blood-2009-02-205047","article-title":"Mislabeled units of umbilical cord blood detected by a quality assurance program at the transplantation center","volume":"114","author":"McCullough","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2022.08.007_b0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fonc.2013.00238","article-title":"Cord Blood Transplantation: Can We Make it Better?","volume":"3","author":"Metheny","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2022.08.007_b0470","first-page":"288","article-title":"One-unit versus two-unit cord-blood transplantation","volume":"372","author":"Wagner","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.humimm.2022.08.007_b0475","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","article-title":"Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies","volume":"115","author":"Barker","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.humimm.2022.08.007_b0480","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/s41409-021-01313-x","article-title":"Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)","volume":"56","author":"Rafii","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0485","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bbmt.2019.11.017","article-title":"Evaluation of Cord Blood Total Nucleated and CD34(+) Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry","volume":"26","author":"Barker","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0490","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2013-05-506253","article-title":"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy","volume":"123","author":"Eapen","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humimm.2022.08.007_b0495","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2352-3026(17)30104-7","article-title":"Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis","volume":"4","author":"Eapen","year":"2017","journal-title":"Lancet Haematol"},{"issue":"14","key":"10.1016\/j.humimm.2022.08.007_b0500","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1182\/blood-2010-11-317271","article-title":"HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection","volume":"118","author":"Stevens","year":"2011","journal-title":"Blood"},{"issue":"47","key":"10.1016\/j.humimm.2022.08.007_b0505","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1073\/pnas.0910310106","article-title":"Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies","volume":"106","author":"van Rood","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.humimm.2022.08.007_b0510","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.bbmt.2012.07.010","article-title":"Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy","volume":"18","author":"Rocha","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humimm.2022.08.007_b0515","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3324\/haematol.2020.264424","article-title":"Use of the HLA-B leader to optimize cord blood transplantation","volume":"106","author":"Petersdorf","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0520","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2008.365","article-title":"KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia","volume":"23","author":"Willemze","year":"2009","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humimm.2022.08.007_b0525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbmt.2012.09.017","article-title":"Impact of the Direction of HLA Mismatch on Transplantation Outcomes in Single Unrelated Cord Blood Transplantation","volume":"19","author":"Kanda","year":"2013","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"7","key":"10.1016\/j.humimm.2022.08.007_b0530","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.humimm.2022.08.007_b0535","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3324\/haematol.2016.158584","article-title":"The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia","volume":"102","author":"Brunstein","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0540","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbmt.2016.12.633","volume":"23","author":"Barba","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.humimm.2022.08.007_b0545","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0550","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1182\/bloodadvances.2020002444","article-title":"\u03b1\u03b2 T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies","volume":"5","author":"de Witte","year":"2021","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0555","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/pbc.25352","article-title":"Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability","volume":"62","author":"Shook","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.humimm.2022.08.007_b0560","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.08.007_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.605726","article-title":"GVHD Prophylaxis 2020","volume":"12","author":"Gooptu","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2022.08.007_b0570","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2018.02.006","article-title":"Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most","volume":"24","author":"Shaw","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0575","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2021.6846","article-title":"Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors","volume":"8","author":"Guru Murthy","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0580","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3324\/haematol.2013.089979","article-title":"Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related\/unrelated donors","volume":"99","author":"Servais","year":"2014","journal-title":"Haematologica"},{"issue":"5562","key":"10.1016\/j.humimm.2022.08.007_b0585","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0590","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humimm.2022.08.007_b0595","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.humimm.2022.08.007_b0600","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2022.08.007_b0605","doi-asserted-by":"crossref","first-page":"e0169512","DOI":"10.1371\/journal.pone.0169512","article-title":"Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study","volume":"12","author":"Neuchel","year":"2017","journal-title":"PLoS ONE"},{"issue":"15","key":"10.1016\/j.humimm.2022.08.007_b0610","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1182\/blood-2009-08-236943","article-title":"Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Venstrom","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humimm.2022.08.007_b0615","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.humimm.2022.08.007_b0620","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/bloodadvances.2019001053","article-title":"KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation","volume":"4","author":"Weisdorf","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2022.08.007_b0625","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13287-021-02277-x","article-title":"Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future","volume":"12","author":"Lamb","year":"2021","journal-title":"Stem Cell Res. Ther."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:56:20Z","timestamp":1759319780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":125,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0198885922001628"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.08.007","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current donor selection strategies for allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}